References
1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med . 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316
2. Cevik M, Bamford C, Ho A. COVID-19 pandemic – A focused review for clinicians. Clin Microbiol Infect . 2020. doi:10.1016/j.cmi.2020.04.023
3. Dong Y, Mo X, Hu Y, et al. Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China.Pediatrics . 2020;145(6):e20200702. doi:10.1542/peds.2020-0702
4. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep . 2020;69(14):422-426. doi:10.15585/mmwr.mm6914e4
5. Centro de Coordinación Alertas y Emergencias Sanitarias del Gobierno de España. Actualización no 50. Enfermedad por el coronavirus (COVID-19). 20.03.2020. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_50_COVID-19.pdf. Published 2020. Accessed April 27, 2020.
6. Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer . 2020;132:11-16. doi:10.1016/j.ejca.2020.03.021
7. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European conference on infections in leukaemia (ECIL-4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis . 2013. doi:10.1093/cid/cis844
8. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol . 2020;21(3):335-337. doi:10.1016/S1470-2045(20)30096-6
9. Dai M-Y, Liu D, Liu M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak. SSRN Electron J . 2020. doi:10.2139/ssrn.3558017
10. Aylward, Bruce (WHO); Liang W (PRC). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) .; 2020.
11. von Lilienfeld-Toal M, Berger A, Christopeit M, et al. Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer . 2016. doi:10.1016/j.ejca.2016.08.015
12. Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A. Characteristics and outcomes of coronavirus infection in children: The role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc . 2019;8(1):21-28. doi:10.1093/jpids/pix093
13. Bonet RP, Romaguera EP, Poveda SV. Registro Español de Tumores Infantiles Estadísticas Cáncer infantil en España cohortes. Minist Sanidad, Serv Soc e Igual . 2019. https://www.uv.es/rnti/informes.html.
14. Centro Nacional de Epidemiología. Distribución geográfica de los casos totales y los casos de las últimas 24h (obtenidos a partir de la declaración agregada de casos del Ministerio de Sanidad). https://cnecovid.isciii.es/covid19/. Accessed May 13, 2020.
15. de Rojas T, Pérez-Martínez A, Cela E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer . 2020;(April):e28397. doi:10.1002/pbc.28397
16. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl . 2020:0-1. doi:10.1002/lt.25756
17. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children.N Engl J Med . 2020. doi:10.1056/NEJMc2005073
18. Chen Z, Xiong H, Li JX, et al. COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report.Zhonghua Xue Ye Xue Za Zhi . 2020. doi:10.3760/cma.j.issn.0253-2727.2020.0004
19. André N, Rouger-Gaudichon J, Brethon B, et al. COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms? Pediatr Blood Cancer . 2020;(April):e28392. doi:10.1002/pbc.28392
20. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr Int J Paediatr . 2020. doi:10.1111/apa.15270
21. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression.Lancet . 2020;395(10229):1033-1034. doi:10.1016/S0140-6736(20)30628-0
22. Harahsheh AS, Dahdah N, Newburger JW, et al. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic. J Pediatr . April 2020:S0022-3476(20)30556-4. doi:10.1016/j.jpeds.2020.04.052
23. Sankar J, Dhochak N, Kabra SK, Lodha R. COVID-19 in Children: Clinical Approach and Management. Indian J Pediatr . 2020. doi:10.1007/s12098-020-03292-1
24. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm” in COVID-19.’ J Infect . 2020. doi:10.1016/j.jinf.2020.03.037
25. Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2.J Pediatric Infect Dis Soc . 2020. doi:10.1093/jpids/piaa045
26. Yang C, Li C, Wang S. Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection.Pediatr Blood Cancer . 2020;67(5):1-2. doi:10.1002/pbc.28248
27. Balduzzi A, Brivio E, Rovelli A, et al. Lessons After the Early Management of the COVID-19 Outbreak in a Pediatric Transplant and Hemato-Oncology Center Embedded within a COVID-19 Dedicated Hospital in Lombardia, Italy. Estote Parati. (Be Ready.). SSRN Electron J . 2020. doi:10.2139/ssrn.3559560
28. Sullivan M, Bouffet E, Rodriguez-Galindo C, et al. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.Pediatr Blood Cancer . April 2020. doi:10.1002/pbc.28409